Good practice code for the management of cancer pain;Códigode buena práctica para el control del dolor oncoĺogico

Revista de la Sociedad Espanola del Dolor

Volumn 18, Issue 2, 2011, Pages 98-117

  Gonzalez Escalada J R ^a   Camba, A ^b,c   Casas, A ^d   Gascon P ^e   Herruzo, I ^c,f   Nunez Olarte J M ^g   Ramos Aguerri, A ^a   Trelis, J ^c,h   Torres Morera, Luis Miguel ⁱ  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b Servicio de Anestesiología Reanimación Y Tratamiento del Dolor   (Spain)

^c SED ^*  (Spain)

^d Área Sectorial de Oncología Médica   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^h HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

ⁱ HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Breakthrough pain; Cancer; Cancer pain; Fentanyl; Opioids

Indexed keywords

ANALGESIA; ARTICLE; AWARENESS; CANCER PAIN; CANCER PATIENT; DOCTOR PATIENT RELATION; FEAR; GOOD CLINICAL PRACTICE; HEALTH CARE PERSONNEL; HUMAN; MEDICAL SOCIETY; PATIENT CARE; QUALITY OF LIFE;

EID: 84874985341     PISSN: 11348046     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (121)

1. Cherny NI, Portenoy RK. The management of cancer pain. CA Cancer J Clin1994;44:263-303.
2. Zhukovsky IDS, Gorowski E, Hausdorff J, Napolitano B, Lesser M. Unmet analgesic needs in cancer patients. J Pain Symptom Manage 1995;10:113-9.
3. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KS. Validation of World Health Organization guidelines for cancer pain relief. Pain 1995;63:65-76.
4. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995;61:277-84.
5. Levy M. Pharmacologic treatment of cancer pain. N Engl J Med 1996;335:1124-32.
6. Portenoy RK, Lesage P. Management of cancer pain. Lancet 1999;353:1695-700. (Pubitemid 29224537)
7. Whitecar PS, Jonas AP, Clasen ME. Managing pain in the dying patient. Am Fam Physician 2000;61:755-64. (Pubitemid 30111397)
8. Sepulveda C, Marlin A, Yoshida T, Ulrich A. Palliative care: the World Health Organization's global perspective. J Pain Symptom Manage 2002;24:91-6. (Pubitemid 35291983)
9. Foley KM. Pain assessment and cancer pain syndromes. In: Doyle D, Hanks GWC, Calman K, Cherny N, editors. Oxford textbook of palliative medicine. 3rd ed. New York: Oxford University Press; 2003.
10. Bruera E, Kim HN. Cancer pain. JAMA 2003;290:2476-9. (Pubitemid 37430548)
11. Khosravi Shahi P, Del Castillo Rueda A, Pérez Manga G. Manejo del dolor oncológico. An Med Interna 2007;24:554-7.
12. Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ. Chronic pain in the cancer survivor: a new frontier. Pain Med 2007;8:189-98.
13. Wandler E, Kramer EL, Sherman O, Babb J, Scarola J, Rafii M. Diffuse FDG shoulder uptake on PET is associated with clinical findings of osteoarthritis. AJR Am J Roentgenol 2005;185:797-803.
14. Sharpe M, Strong V, Allen K, Rush R, Postma K, Tulloh A, et al. Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs. Br J Cancer 2004;90:314-20. (Pubitemid 38250622)
15. Reich M. Depression and cancer: recent data on clinical issues, research challenges and treatment approaches. Curr Opin Oncol 2008;20:353-9.
16. Chen ML, Chang HK. Physical symptom profiles of depressed and nondepressed patients with cancer. Palliat Med 2004;18:712-8.
17. Novy D, Berry MP, Palmer JL, Mensing C, Willey J, Bruera E. Somatic symptoms in patients with chronic non-cancer-related and cancer-related pain. J Pain Symptom Manage 2005;29:603-12. (Pubitemid 40826483)
18. Strong V, Waters R, Hibberd C, Murray G, Walker J, McHugh G, et al. Depression care for people with cancer; a randomized trial of a complex intervention. Lancet 2008;5:8-10.
19. Walker J, Cassidy J, Sharpe M. The second Symptom Management Research Trial in Oncology (SMaRT Oncology-2): a randomised trial to determine the effectiveness and cost-effectiveness of adding a complex intervention for major depressive disorder to usual care for cancer patients. Trials 2009;10:18.
20. Gordon DB, Dahl JJ, Micsskanski C, McCarberg B, Todd KH, Paice JA, et al. American Pain Society recommendations for improving the quality of acute and cancer pain management. American Pain Society Quality of Care Task Force. Arch Intern Med 2005;165:1574-80. (Pubitemid 41124150)
21. Cleeland CS, Janjan NA, Scott CB, Seiferheld WF, Curran WJ. Cancer pain management by radiotherapists: a survey of radiation therapy oncology group physicians. Int J Radiat Oncolo Biol Phys 2000;47:203-8. (Pubitemid 30179696)
22. Steenland E, Leer JW, van Houwelingen H, Post WJ, van den Hout WB, Kievit J, et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 1999;52: 101-9. (Pubitemid 29461077)
23. NCCN Clinical Practice Guidelines in OncologyTM (v1) 2009. Adult cancer pain
24. Deng G, Cawhisth BR. Integrative oncology; complementary therapies for pain anxiety and mood disturbance. C A Cancer. J Clin 2005;55:109-16. (Pubitemid 40372905)
25. Zech DF, Griund S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for Cancer Pain relief; a 10 year prospective study. Pain 2005;63:65-76.
26. Casinello J, Camps C. Guía rápida de tratamiento médico del dolor oncológico. Madrid: SEOM; 2005.
27. Fuentes, Canales, Vayrada. Tratamiento de soporte en oncología radioterápica. Madrid: SEOR; 2003.
28. Ministerio de Sanidad y Consumo, SECPAL. Guía de criterios de calidad en cuidados paliativos. Madrid: Ministerio de Sanidad y Consumo; 2002.
29. Abordaje integral del paciente oncológico avanzado en atención primaria. Atención Primaria. semFYC 2006;38:1-23.
30. Recomendaciones Rec (2003) 24 del comité de Ministros de los estados miembros sobre organización de cuidados paliativos. Madrid: Agencia de Calidad del sistema Nacional de Salud. Ministerio de Sanidad y Consumo; 2005.
31. Estrategia Nacional de Salud en Cuidados Paliativos. Madrid: Ministerio de Sanidad y Consumo; 2007. p. 35.
32. Roth AJ, Massie MJ. Anxiety and its management in advanced cancer. Curr Opin Support Palliat Care 2007;1:50-6.
33. Breitbart W. Psychiatric management of cancer pain. Cancer 1989;63:2336-42. (Pubitemid 19141081)
34. Smith WB, Gracely RH, Safer MA. The meaning of pain: cancer patient's rating and recall of pain intensity and affect. Pain 1998;78:123-9. (Pubitemid 28517950)
35. Stark D, Kiely M, Smith A, Velikova G, House A, Selby P. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol 2002;20:3137-48. (Pubitemid 34791104)
36. Steinman RH. The cancer patient with anxiety and chronic pain. International Association for the Study of Pain. IASP. September 2009. Volume XVII, Issue 4.
37. Levy MH, Samuel TA. Management of Cancer Pain. Seminars in Oncology 2005;32:179-93. (Pubitemid 40463294)
38. Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management: stepping up the quality of its evaluation. JAMA 1995;274:1870-3. (Pubitemid 26001265)
39. Van der Beuken J, van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, et al. Prevalence of pain in patients with cancer: a systemic review of the past 40 years. Ann Oncol 2007;18:1437-49. (Pubitemid 47365475)
40. Deng G, Cassileth BR. Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance. CA Cancer J Clin 2005;55:109-16. (Pubitemid 40372905)
41. Smith WB, Gracely RH, Safer MA. The meaning of pain: cancer patient's rating and recall of pain intensity and affect. Pain 1998;78:123-9. (Pubitemid 28517950)
42. Fisch MJ, Burton AW, editors. Cancer Pain Management. New York: Mc Graw Hill; 2007.
43. Grossman SA. Cancer pain. In: Abeloff MD, et al. Abeloff's Clinical Oncology. 4th ed. Philadelphia, PA: Churchill Livingstone; 2008. p. 565.
44. Higginson IJ, Heran J, Murtagh F. Epidemiology of cancer pain. En: Sykes N, Bennett M, Yuan CS, editors. Textbook of Clinical Pain Management - cancer volume. 2nd ed. London: Hodder Arnold; 2008. p. 13-26.
45. Stjenrsward J, Gomez-Batiste X. Palliative Medicine - the global perspective: closing the know-do gap. En: Walsh D, Caraceni A, Fainsinger R, Foley K, Glare P, Goh C, et al, editors. Palliative Medicine. Philadelphia: Elsevier; 2008. p. 2-8.
46. Bilbeny N. Medición del dolor en clínica. En: Paeile C, Saavedra A, editores. El dolor. Aspectos básicos y clínicos. Santiago: Mediterráneo; 1990. p. 87-101.
47. Bugedo G, Dagnino J, Muñoz H, Torregrosa S. Escala visual análoga: Comparación de seis escalas distintas. Rev Chil Anestesia 1989;18:132.
48. Chapman CR, Casey KL, Dubner R, Foley KM, Gracely RH, Reading AE. Pain measurement: an overview. Pain 1985;22:1-31. (Pubitemid 15037578)
49. Huskisson EC. Measurement of pain. Lancet 1974;ii:1127-31.
50. Katz J, Melzack R. Measurement of pain. Anesth Clin North Am 1992;10:229-46.
51. Huskisson EC. Visual analogue scales. In: Meltzack R. Pain measurement and assessment. New York: Raven Press; 1983. p. 33-7.
52. Ohnhanus E, Adler R. Methodological problems in measurement of pain: A comparison between the verbal rating scale and the visual analogue scale. Pain 1975;1:374.
53. Portenoy RK, Miransky J, Thaler HT, Hornung J, Bianchi C, Cibas-Kong I, et al. Pain in ambulatory patients with lung or colon cancer: prevalencia, characteristics, and effect. Cancer 1992;70:1616-24.
54. Fainsinger RL, Fairchild A, NeKolaichuk C, Lawior P, Lowe S, Hanson J. Is pain Intensity a predictor of the complexity of cancer pain management? J Clin Oncol 2009;27:585-90.
55. Appelgren L, Nordborg C, Sjöberg M, Karlsson PA, Nitescu P, Curelaru I. Spinal epidural metastasis: implications for spinal analgesia to treat "refractory" cancer pain. J Pain Symptom Manage 1997;13:25-42. (Pubitemid 27063352)
56. Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence and caracteristcs. Pain 1990;41:273-81. (Pubitemid 20187930)
57. Bruera E, Schoeller T, Wenk R, MacEachern T, Marcelino S, Hanson J, et al. A prospective multicentre assessment of de Edmonton staging system for cancer pain. J Pain Symptom Management 1995;10:348-55.
58. Grande LA, O'Donnell BR, Fitzgibbon DR, Terman GW. Ultra-low dose Ketamina and memantine treatment for pain in an opioid-tolerant oncology patient. Anesth Analg 2008;107:1380-3.
59. Von Moos R, Strasser F, Gillessen S, Zaugg K. Metastatic bone pain: treatment options with an emphasis on biphosphonates. Support Care Cancer 2008;16:1105-15.
60. Polati E, Luzzani A, Schweiger V, Finco G, Ischia S. The role neurolytic celiac plexus block in the treatment of pancreatic cancer pain. Trasplant Proc 2008;40:1200-4.
61. Newsome S, Frawley BK, Argoff CE. Intrathecal analgesia for refractory pain. Curr Pain Headache Rep 2008;12:249-56.
62. Staats PS. Long-term intrathecal ziconotida therapy: a case study and discussion. Neuromodulation 2001;4:121-6. (Pubitemid 32645986)
63. Staas PS, Yearwood T, Charapata SG, Presley RW, Wallace MS, Byas-Smith M, et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA 2004;291(1):63-70. (Pubitemid 38040536)
64. Uchida K. Radiofrequency treatment of the thoracic paravertebral nerve combined with glucocorticoid for refractory neuropathic pain following breast cancer surgery. Pain Physician 2009;12:277-83.
65. Rainone F. Treating adult cancer pain in primary care. J Am Board Fam Pract 2004;17:S48-56.
66. Collado A, Torres X, Arias A, Ruiz-López R, Muñoz- Gómez J. Tratamiento multidisciplinar en pacientes con dolor crónico en situación de baja laboral. Rev Soc Esp Dolor 2004;11: 203-9. (Pubitemid 38917435)
67. Mínguez Martí A, Monsalve Dolz V, Valia Vera JC, et al. Unidad del dolor. Integración del farmacéutico del hospital en un equipo multidisciplinar. Farm Hosp 1999;23:313-9. (Pubitemid 29517284)
68. Monsalve V, Gómez-Carretero P, Soriano J. Intervención psicológica en dolor oncológico: un estudio de revisión. Psicooncología 2006;3:139-52.
69. Brennan F, Carr DB, Cousins M. Pain management: a fundamental human right. Anesth Analg 2007;105:205-21. (Pubitemid 46975867)
70. Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 1999;81:129-34. (Pubitemid 29199908)
71. Gómez-Batiste X. Breakthrough cancer pain: prevalence and characteristics in patients in Catalonia, Spain. J Pain Symptom Manage 2002;24:45-52.
72. Mercadante S, Radbruch L, Caraceni A, Cherny N, Kaasa S, Nauck F, et al. Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer 2002;94:832-9. (Pubitemid 34132314)
73. Caraceni A, Martini C, Zecca E, Portenoy RK, Ashby MA, Hawson G, et al. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliat Med 2004;18:177-83. (Pubitemid 38771657)
74. Bruera E, Schoeller T, Wenk R, MacEachern T, Marcelino S, Hanson J, et al. A prospective multicenter assesment of the Edmonton Staging Symptom for cancer pain. J Pain Symptom Manage 1995;10:348-55.
75. Maltoni M, Scarpi E, Modonesi C, Passardi A, Calpona S, Turriziani A, et al. A validation study of the WHO analgesic ladder: a two-step vs three-step strategy. Support Cancer Care 2005;13:888-94. (Pubitemid 41502248)
76. Gracia A, Trelis J, Martínez-Calderón F, Pérez-Hernández C, Sánchez-Dominguez F, Zsolt I. Citrato de fentanilo oral transmucosa en el tratamiento del dolor irruptivo en pacientes con cáncer en España. Resultados del estudio EDIPAP. Rev Soc Esp Dolor 2004;11:184-96. (Pubitemid 38917433)
77. Wlaker G, Wilcock A, Manderson C, Weller R, Crosby V. The acceptability of different routes of administration of analgesia for breakthrough pain. Palliat Med 2003;17:219-21. (Pubitemid 36432601)
78. Davies AN, Vriens J, Kennett A, McTaggart M. An observational study of oncology patients' utilization of breakthrough pain medication. J Pain Symptom Manage 2008;35:406-11.
79. William L, Macleod R. Management of breakthrough pain in patients with cancer. Drugs 2008;68:913-24. (Pubitemid 351652921)
80. Zeppetella G. Impact and management of breakthrough pain in cancer. Curr Opin Support Palliat Care 2009;31-6.
81. Stjenrsward J, Gomez-Batiste X. Palliative Medicine - the global perspective: closing the know-do gap. En: Walsh D, Caraceni A, Fainsinger R, Foley K, Glare P, Goh C, editors. Palliative Medicine. Philadelphia: Elsevier; 2008. p. 2-8.
82. Cassell EJ. Suffering. En: Walsh D, Caraceni A, Fainsinger R, Foley K, Glare P, Goh C, editors. Palliative Medicine. Philadelphia: Elsevier, 2008. p. 46-51.
83. Lichtental WG, Olden M, Pessin H, Breitbart W. The desire for death. En: Walsh D, Caraceni A, Fainsinger R, Foley K, Glare P, Goh C, editors. Palliative Medicine. Philadelphia: Elsevier; 2008. p. 55-9.
84. Hauser K. Clinical symptom assessment. En: Walsh D, Caraceni A, Fainsinger R, Foley K, Glare P, Goh C, editors. Palliative Medicine. Philadelphia: Elsevier; 2008. p. 325-33.
85. Glare P, Vigano A. Determining prognosis. En: Walsh D, Caraceni A, Fainsinger R, Foley K, Glare P, Goh C, editors. Palliative Medicine. Philadelphia: Elsevier; 2008. p. 657-62.
86. Foley K. Acute and chronic cancer pain syndromes. En: Doyle D, Hanks G, Cherny N, Calman, editors. Oxford Textbook of Palliative Medicine. 3rd ed. Oxford: Oxford University Press; 2004. p. 298-315.
87. Mercadante S. Challenging pain problems. En: Walsh D, Caraceni A, Fainsinger R, Foley K, Glare P, Goh C, editors. Palliative Medicine. Philadelphia: Elsevier; 2008. p. 1425-30.
88. Portenoy RK, Forbes K, Lussier D, Hanks G. Difficult pain problems: an integrated approach. En: Walsh D, Caraceni A, Fainsinger R, Foley K, Glare P, Goh C, editors. Palliative Medicine. Philadelphia: Elsevier; 2008. p. 438-58.
89. Given B, Given CW, Sikorski A, Jean S, McCorkle R, Champion V, et al. Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points? J Pain Symptom Manage 2008;35(2):126-35.
90. Randall F. Ethical issues in cancer pain management. En: Sykes N, Bennett M, Yuan CS, editors. Textbook of Clinical Pain Management - cancer volume. 2nd ed. London: Hodder Arnold; 2008. p. 93-100.
91. Cherny NI, Portenoy RK. The management of cancer pain. CA Cancer J Clin 1994;44:263-303.
92. Apolone G, Corli O, Caraceni A, Negri E, Deandrea S, Montanari M, Greco MT; Cancer Pain Outcome Research Study Group (CPOR SG) Investigators. Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study Group. Br J Cancer 2009;100:1566-74.
93. World Health Organization. Cancer pain relief. Geneva, 1986 (aplicación 2007: www.who.int/medicines/areas/quality-safety/delphi- study-pain-guidelines.pdf)
94. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer 1987;59:850-6. (Pubitemid 17018769)
95. Levy MH. Pharmacological treatment of cancer pain. N Eng J Med 1996;10:1124-32.
96. Hassenbusch SJ, Portenoy RK. Current practices in intraspinal therapy-a survey of clinical trends and decision making. J Pain Symptom Manage 2000;20:S4-S11.
97. Walker SM, Goudas LC, Cousins MJ, Carr DB. Combination spinal analgesic chemotherapy: a systemic review. Anesth Analg 2002;95:674-715. (Pubitemid 35006863)
98. Cormie PJ, Nairn M, Welsh J; Guideline Development Group. Control of pain in adults with cancer: summary of SIGN guidelines. BMJ 2008;337:1106-12.
99. Forbes K. Opioids: beliefs and myths. J Pain Palliat Care Pharmacother 2006;20:33-5. (Pubitemid 44289648)
100. Mercadante S, Villari P, Ferrera P, Casuccio A. Opioid-induced or pain relief-reduced symptoms in advanced cancer patients? Eur J Pain 2006;10:153-9. (Pubitemid 41727765)
101. Pu L, Bao Gb, Xu NJ, Ma L, Pei G. Hippocampal long term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates. J Neurosci 2002;22:1914-21. (Pubitemid 35386310)
102. Ho ST, Wang JJ, Huang JC, Lin MT, Liaw WJ. The magnitude of acute tolerance to morphine analgesia: concentration-dependent or time-dependent. Anesth Analg 2002;95:948-51.
103. Sees KL, Clark HW. Opioid use in the treatment of chronic pain: assessment of addiction. J Pain Symptom Manage 1993;8:257-64. (Pubitemid 23191389)
104. Schug SA, Zech D, Grond S, Jung H, Meuser T, Stobbe B. A long-term survey of morphine in cancer pain patients. J Pain Symptom Manage 1992;7:259-66.
105. Højsted J, Sjøgren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 2007;11:490-518. (Pubitemid 46670780)
106. Cherny N, Ripamonti C, Pereira C, et al. Strategies to manage the adverse effects of oral morphine:an evidence-based report. J Clin Oncol 2001;19:2542-54. (Pubitemid 32391226)
107. Hanks GW, Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 2001;84:587-93. (Pubitemid 32238990)
108. Mercadante S, Bruera E. Opioid switching a systematic and critical review. Cancer Treat Rev 2006;32:304-15. (Pubitemid 44502005)
109. Olsen AK, Sjogren P. Neurotoxic effects of opioids. Eur J Palliat Care 1996;3:139-42.
110. Thomas JR, von Gunten CF. Pain in terminally patients. Guidelines for Pharmacological Management. Drugs 2003;17:621-31. (Pubitemid 36920540)
111. Geppetti P, Benemei S. Pain treatment with opioids: achieving the minimal effective and the minimal interacting dose. Clin Drug Investig 2009;29(Supl.1):3-16.
112. Steenland E, Leer JW, van Houwelingen H, Post WJ, van den Hout WB, et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study (Dutch Study). Radiother Oncol 1999;52:101-9. (Pubitemid 29461077)
113. Yarnold JR. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party. Radiother Oncol 1999; 52:111-21. (Pubitemid 29461078)
114. Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M 3rd, et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. (RTOG Study). J Natl Cancer Inst 2005;97:798-804. (Pubitemid 40909122)
115. Ratanatharathorn. Metaanálisis IJRBOP: 1999;44: 1-18.
116. McQuay HJ, Collins SL, Carroll D, Moore RA. Radiotherapy for the palliation of painful bone metastases (Cochrane Review). The Cochrane Library Issue 1, 2002.
117. Rose. Recomendaciones de la A.C.R. IJRBOP. 1998;40:117.
118. Metaanálisis. IJRBOP 2003;55:594-6.
119. Waller A, Caroline NL. Handbook of Palliative Care in Cancer. Boston: Buterworth-Heinemann; 1996.
120. Bernhard J, Dietrich D, Scheithauer W, Gerber D, Bodoky G, Ruhstaller T, et al. Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial-SAKK 44/00-CECOG/PAN.1. 3.001. J Clin Oncol 2008;26:3695-701.
121. Martínez Martínez B, Casado Sáez E. Tratamientos con efecto analgésico en las metástasis óseas en dolor y cáncer. Hacia una oncología sin dolor. En: González Barón M, Ordóñez Gallego A, editores. Madrid: Editorial Médica Panamericana; 2003. p. 296-323.